Benda subsidiary developing potential AIDS vaccine
Benda Pharmaceutical, a Chinese pharmaceutical company that produces traditional Chinese and conventional medicines, as well as Gendicine, the world’s first commercialized gene therapy medicine for cancer has said that its subsidiary SiBiono has developed an anti-AIDS gene therapy. This marks SiBiono’s and Benda’s anticipated entry into the $14 billion Chinese anti-AIDS drug market.
As part of [...]